MARISSA SAFFARINI: Open Payments
NPI 1093332082 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 9 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $88 |
| Amgen Inc. | 3 | $47 |
| Novo Nordisk Inc | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
Products named: AVEIR, REPATHA, Wegovy, JOT DX, AMVUTTRA.
Industry payments across AZ — which companies pay providers there.
